Playing the momentum game has its perils. Jim Cramer says beware the strong dollar and the loss of business to Europe.
Cramer likes Ryanair, Pfizer and MeadWestvaco but is avoiding Rovi Corporation, Five Prime Therapeutics and Avon Products.
Cramer is betting natural foods purveyor WhiteWave is a better way to go than Kraft, now part of Heinz.
As Cramer predicted, biotechs have started to cool. What should investors do next? Nothing, he advises.
Technology? Transports? Banks? The market always looks for leaders but Cramer sees none leading the charge.